Joseph Fiore, MD
Obstetrics & Gynecology · Huntsville, ALNPI 1982675336
Payments from drug & device makers
Across 71 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$516
- Astellas Pharma US Inc$119
- Sumitomo Pharma America, Inc.$115
- Intuitive Surgical$109
- Channel Medsystems, Inc.$82
- Mayne Pharma Commercial LLC$78
- plus $403 from 16 others
What the payments were for
- Food & beverage$1,36496%
- Education$584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $516 |
| Astellas Pharma US Inc | 5 | $119 |
| Sumitomo Pharma America, Inc. | 5 | $115 |
| Intuitive Surgical | 2 | $109 |
| Channel Medsystems, Inc. | 1 | $82 |
| Mayne Pharma Commercial LLC | 3 | $78 |
| AMAG Pharmaceuticals, Inc. | 2 | $41 |
| Shield Therapeutics Inc | 2 | $36 |
| Mylan Pharmaceuticals Inc. | 2 | $34 |
| Minerva Surgical, Inc | 2 | $33 |
| Pfizer | 2 | $32 |
| Hologic Sales And Service, LLC | 2 | $27 |
| Medtronic | 1 | $27 |
| Meditrina | 2 | $27 |
| Roche Diagnostics Corporation | 1 | $24 |
| Convatec Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Organon | 1 | $20 |
| Scynexis, Inc. | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $12 |
How this compares
$1,422 in reported general payments places this provider in the 45th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 66 | $3,186 |
| OsphenaOspemifene | 12 | $2,858 |
| ProgesteroneProgesterone, Micronized | 44 | $2,265 |
| Estradiol (Twice Weekly)Estradiol | 21 | $2,265 |
| ValacyclovirValacyclovir Hcl | 18 | $860 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $326 |
| Np ThyroidThyroid,pork | 11 | $151 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Huntsville
- Anne ReidyHuntsville$54K
- Guy MiddletonDothan$5.6M
- Charles SharpBirmingham$2.8M
- John WidemanCullman$2.3M
- Charles RogersMobile$1.8M
- Ronald OrsoBirmingham$1.6M
- Amy McCoyMobile$1.2M
- Theodore CatranisMobile$994K
- Theodore TsaltasBirmingham$853K
- Janeen ArbuckleBirmingham$601K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.